In certain cancers, such as renal cell carcinoma with hereditary leiomyomatosis (HLRCC), loss-of-function mutations in fumarate hydratase (FH) lead to accumulation of fumarate. Here, FH is linked to hereditary leiomyomatosis and renal cell cancer.